| mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.19 |
0.0002 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
CI-1040 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0008 |
| mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
| mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.001 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |